Cullinan Associates’s Dorman Products DORM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-25,000
Closed -$2.02M 251
2022
Q4
$2.02M Hold
25,000
0.11% 121
2022
Q3
$2.05M Hold
25,000
0.13% 114
2022
Q2
$2.74M Hold
25,000
0.17% 108
2022
Q1
$2.38M Hold
25,000
0.12% 118
2021
Q4
$2.83M Hold
25,000
0.14% 115
2021
Q3
$2.37M Hold
25,000
0.13% 116
2021
Q2
$2.59M Hold
25,000
0.15% 112
2021
Q1
$2.57M Buy
+25,000
New +$2.49M 0.15% 106

Other funds holding DORM

Cullinan Associates's DORM Position: Q1 2023 in Review

Cullinan Associates sold out of Dorman Products (DORM) in Q1 2023, closing a stake of 25,000 shares — an estimated $2.02M sold.

Cullinan Associates first reported a position in DORM in Q1 2021 and held it in 8 quarters. The position peaked at $2.83M in Q4 2021. 238 funds tracked by Wall St. Rank hold DORM as of Q1 2023.

  • Cullinan Associates reported no remaining Dorman Products position as of Q1 2023 after selling out during the quarter.
  • Cullinan Associates sold 25,000 Dorman Products shares in Q1 2023, an estimated $2.02M.
  • Cullinan Associates first reported a position in Dorman Products in Q1 2021 and held it in 8 quarters.
  • Cullinan Associates's Dorman Products position peaked at $2.83M in Q4 2021.
  • 238 funds tracked by Wall St. Rank held Dorman Products as of Q1 2023.

Based on Cullinan Associates's 13F filing for Q1 2023, filed 5 Apr 2023.